FDA Import Refusal 799-9703977-1/101/1 — Suraksha Pharma Pvt Ltd
The FDA refused shipment 799-9703977-1/101/1 from Suraksha Pharma Pvt Ltd (India) on Mar 5, 2024. The refused product falls under Drugs and Biologics — GABAPENTIN (ANTI-DEPRESSANT). Cited charges: 118,3280,75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Mar 5, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61NDA69 GABAPENTIN (ANTI-DEPRESSANT)
- Charges
- 118,3280,75